黛安神对神经症的疗效评价  

EVALUATION ON THERAPEUTIC EFFECT OF DEANXIT IN THE TREATMENT OF NEUROSIS

作　　者：杨康女[1,2] 蔡文儒[1,2] 吕佩源[1,2] 刘昌林 赵宝华[1,2] 杨增顺 

机构地区：[1]河北省人民医院 [2]石家庄铁路中心医院

出　　处：《中国新药杂志》1997年第3期201-202,共2页Chinese Journal of New Drugs

摘　　要：对患有神经症和脑卒中后抑郁症的３０例病人进行口服黛安神临床观察，结果显示，治疗忧郁、焦虑、强迫症状和睡眠障碍等类因子的总平均分分别于７ｄ，１５ｄ降低７．７和６．１９，汉密尔顿抑郁量表（ＨＡＭＤ）平均分在同期分别降低３７．８％和６９．１％。表明黛安神有明显疗效。常规剂量应用未见明显副作用。patients with neurosis and melancholia after cerebal apoplexy were treated with melitracen and flupentioxal combination.Results showed that the total average marks on melancholia,anxiety,complusion and sleeping disturbance reduced 7.7 and 6.19 respectively during 7 and 15 d treatment, and the average HAMD(Hamilton depression scale) marks reduced 37.8% and 69.1% at the same time.No apparent ADRs were observed.

关 键 词：黛安神 神经症 药物疗法 

分 类 号：R749.7[医药卫生—神经病学与精神病学]